Health Canada Recalls Blood Pressure Medication Due to Packaging Mix-Up
A recent recall of a blood pressure medication has raised serious health concerns. Health Canada reported a mix-up involving two lots of MAR-Amlodipine 5 milligram tablets. These tablets are primarily used to manage high blood pressure and chest pain.
Details of the Recall
The recall pertains to MAR-Amlodipine tablets produced by Marcan Pharmaceuticals Inc. Some bottles may mistakenly contain midodrine 2.5 milligram tablets instead. Midodrine is a medication designed to treat low blood pressure.
Identifying the Tablets
To determine if they have received the incorrect medication, patients should examine the appearance of their tablets:
- MAR-Amlodipine 5 mg: These are white or off-white, flat, and eight-sided tablets. They feature a line in the middle and have the numbers 210 and 5 printed on one side.
- Midodrine 2.5 mg: These tablets are round and white, marked with M2 on one side, and have a line across the middle on the other side.
Health Risks Associated with the Mix-Up
Health Canada has warned that taking midodrine instead of amlodipine can result in serious health issues. Potential side effects include:
- Dangerous increase in blood pressure
- Dizziness
- Fainting
- Organ damage
Patients experiencing symptoms such as dizziness, unusually high blood pressure, or slow heartbeats should seek immediate medical assistance. Moreover, anyone facing chest pain, a sudden headache, impaired speech, or loss of movement should contact 911 or visit a healthcare professional without delay.
Next Steps for Patients
Health Canada recommends that any patient who finds midodrine tablets in their MAR-Amlodipine bottle should return them to their pharmacy. A replacement will be provided to ensure safe treatment.
